AlzeCure Pharma Financials
| ALZCUR Stock | SEK 1.16 0.03 2.52% |
AlzeCure |
Understanding current and past AlzeCure Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AlzeCure Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in AlzeCure Pharma's assets may result in an increase in income on the income statement.
Please note, the presentation of AlzeCure Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AlzeCure Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AlzeCure Pharma's management manipulating its earnings.
AlzeCure Pharma Stock Summary
AlzeCure Pharma competes with Stille AB, Midsona AB, Precio Fishbone, C Rad, and Novotek AB. AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0010133785 |
| Business Address | HAelsovAegen 7, Huddinge, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.alzecurepharma.se |
| Phone | 46 8 52 80 03 99 |
| Currency | SEK - Swedish Kronor |
You should never invest in AlzeCure Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AlzeCure Stock, because this is throwing your money away. Analyzing the key information contained in AlzeCure Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
AlzeCure Pharma Key Financial Ratios
AlzeCure Pharma's financial ratios allow both analysts and investors to convert raw data from AlzeCure Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of AlzeCure Pharma over time and compare it to other companies across industries.| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Target Price | 11.88 | |||
| Number Of Employees | 14 | |||
| Beta | 0.76 |
AlzeCure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzeCure Pharma's current stock value. Our valuation model uses many indicators to compare AlzeCure Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzeCure Pharma competition to find correlations between indicators driving AlzeCure Pharma's intrinsic value. More Info.AlzeCure Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AlzeCure Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AlzeCure Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AlzeCure Pharma Systematic Risk
AlzeCure Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AlzeCure Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on AlzeCure Pharma correlated with the market. If Beta is less than 0 AlzeCure Pharma generally moves in the opposite direction as compared to the market. If AlzeCure Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AlzeCure Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AlzeCure Pharma is generally in the same direction as the market. If Beta > 1 AlzeCure Pharma moves generally in the same direction as, but more than the movement of the benchmark.
AlzeCure Pharma December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AlzeCure Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AlzeCure Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of AlzeCure Pharma based on widely used predictive technical indicators. In general, we focus on analyzing AlzeCure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AlzeCure Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 17.39 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 5.56 |
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |